Industry Growth Insights published a new data on “Oncology Precision Medicine Market”. The research report is titled “Oncology Precision Medicine Market research by Types (Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics), By Applications (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer), By Players/Companies Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology Precision Medicine Market Research Report
By Type
Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics
By Application
Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer
By Companies
Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioMérieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oncology Precision Medicine Market Report Segments:
The global Oncology Precision Medicine market is segmented on the basis of:
Types
Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Other Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies
- Almac
- ANGLE plc
- Asuragen
- BGI Group
- Bio-Rad Laboratories
- BioMérieux
- Bristol Myers Squibb
- Roche Holding AG
- Gilead Sciences
- Illumina
- Konica Minolta
- LabCorp
- MDxHealth
- Myriad Genetics
- Novartis
- OPKO Health
- Pacific Biosciences
- Quest Diagnostics
- Qiagen
Highlights of The Oncology Precision Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Applied Sciences
- Precision Diagnostics
- Digital Health and Information Technology
- Precision Therapeutics
- By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Other Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology Precision Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncology precision medicine is a field of medical care that uses data and technology to improve the diagnosis, treatment, and prognosis for cancer. Precision medicine is based on the idea that individual patients can be uniquely suited to specific treatments or combinations of treatments, depending on their unique genetic makeup and other factors. By using data from patient records, clinical trials, and other sources, oncologists can identify which patients are likely to respond best to specific therapies. This information can then be used in combination with traditional methods such as surgery or chemotherapy to provide more effective treatment for cancer patients.
Some of the major companies in the oncology precision medicine market are Abbott Laboratories, Agilent Technologies, Almac, ANGLE plc, Asuragen, BGI Group, Bio-Rad Laboratories, BioM©rieux, Bristol Myers Squibb, Roche Holding AG, Gilead Sciences, Illumina, Konica Minolta, LabCorp, MDxHealth, Myriad Genetics, Novartis, OPKO Health, Pacific Biosciences, Quest Diagnostics, Qiagen.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oncology Precision Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oncology Precision Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oncology Precision Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oncology Precision Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oncology Precision Medicine Market Size & Forecast, 2018-2028
4.5.1 Oncology Precision Medicine Market Size and Y-o-Y Growth
4.5.2 Oncology Precision Medicine Market Absolute $ Opportunity
Chapter 5 Global Oncology Precision Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Oncology Precision Medicine Market Size Forecast by Type
5.2.1 Applied Sciences
5.2.2 Precision Diagnostics
5.2.3 Digital Health and Information Technology
5.2.4 Precision Therapeutics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Oncology Precision Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Oncology Precision Medicine Market Size Forecast by Applications
6.2.1 Breast Cancer
6.2.2 Lung Cancer
6.2.3 Colorectal Cancer
6.2.4 Prostate Cancer
6.2.5 Cervical Cancer
6.2.6 Other Cancer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oncology Precision Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oncology Precision Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Oncology Precision Medicine Analysis and Forecast
9.1 Introduction
9.2 North America Oncology Precision Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Oncology Precision Medicine Market Size Forecast by Type
9.6.1 Applied Sciences
9.6.2 Precision Diagnostics
9.6.3 Digital Health and Information Technology
9.6.4 Precision Therapeutics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Oncology Precision Medicine Market Size Forecast by Applications
9.10.1 Breast Cancer
9.10.2 Lung Cancer
9.10.3 Colorectal Cancer
9.10.4 Prostate Cancer
9.10.5 Cervical Cancer
9.10.6 Other Cancer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Oncology Precision Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe Oncology Precision Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Oncology Precision Medicine Market Size Forecast by Type
10.6.1 Applied Sciences
10.6.2 Precision Diagnostics
10.6.3 Digital Health and Information Technology
10.6.4 Precision Therapeutics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Oncology Precision Medicine Market Size Forecast by Applications
10.10.1 Breast Cancer
10.10.2 Lung Cancer
10.10.3 Colorectal Cancer
10.10.4 Prostate Cancer
10.10.5 Cervical Cancer
10.10.6 Other Cancer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Oncology Precision Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Oncology Precision Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Oncology Precision Medicine Market Size Forecast by Type
11.6.1 Applied Sciences
11.6.2 Precision Diagnostics
11.6.3 Digital Health and Information Technology
11.6.4 Precision Therapeutics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Oncology Precision Medicine Market Size Forecast by Applications
11.10.1 Breast Cancer
11.10.2 Lung Cancer
11.10.3 Colorectal Cancer
11.10.4 Prostate Cancer
11.10.5 Cervical Cancer
11.10.6 Other Cancer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Oncology Precision Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Oncology Precision Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Oncology Precision Medicine Market Size Forecast by Type
12.6.1 Applied Sciences
12.6.2 Precision Diagnostics
12.6.3 Digital Health and Information Technology
12.6.4 Precision Therapeutics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Oncology Precision Medicine Market Size Forecast by Applications
12.10.1 Breast Cancer
12.10.2 Lung Cancer
12.10.3 Colorectal Cancer
12.10.4 Prostate Cancer
12.10.5 Cervical Cancer
12.10.6 Other Cancer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Oncology Precision Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Oncology Precision Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Oncology Precision Medicine Market Size Forecast by Type
13.6.1 Applied Sciences
13.6.2 Precision Diagnostics
13.6.3 Digital Health and Information Technology
13.6.4 Precision Therapeutics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Oncology Precision Medicine Market Size Forecast by Applications
13.10.1 Breast Cancer
13.10.2 Lung Cancer
13.10.3 Colorectal Cancer
13.10.4 Prostate Cancer
13.10.5 Cervical Cancer
13.10.6 Other Cancer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oncology Precision Medicine Market: Competitive Dashboard
14.2 Global Oncology Precision Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Agilent Technologies
14.3.3 Almac
14.3.4 ANGLE plc
14.3.5 Asuragen
14.3.6 BGI Group
14.3.7 Bio-Rad Laboratories
14.3.8 BioMérieux
14.3.9 Bristol Myers Squibb
14.3.10 Roche Holding AG
14.3.11 Gilead Sciences
14.3.12 Illumina
14.3.13 Konica Minolta
14.3.14 LabCorp
14.3.15 MDxHealth
14.3.16 Myriad Genetics
14.3.17 Novartis
14.3.18 OPKO Health
14.3.19 Pacific Biosciences
14.3.20 Quest Diagnostics
14.3.21 Qiagen
